Business · 08/01/2010Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Planning for High Absenteeism in Drug Production
Summary
The FDA has released a draft guidance to help manufacturers prepare for emergencies that may lead to high absenteeism at production facilities, ensuring the availability of medically necessary drug products.
Original source language: Federal Register — Health and Human ServicesOpen original release →